Noradrenaline in Multiple Major Blunt Injury (70-year-old)
Noradrenaline should be used cautiously and only as a transient measure in a 70-year-old with multiple major blunt injuries if severe hypotension (systolic BP <80 mmHg) persists despite initial fluid resuscitation, but it should NOT be used routinely to achieve permissive hypotension targets.
Initial Resuscitation Strategy
The primary approach for hypotensive blunt trauma patients is restricted volume replacement with permissive hypotension targeting systolic BP of 80-90 mmHg (MAP 50-60 mmHg) until hemorrhage control is achieved 1. This strategy avoids:
- Dislodgement of blood clots from increased hydrostatic pressure
- Dilutional coagulopathy
- Fluid overload complications
Critical exception: This permissive hypotension strategy is absolutely contraindicated if there is any traumatic brain injury (TBI) or spinal cord injury, where MAP ≥80 mmHg must be maintained to preserve cerebral/spinal perfusion 2.
When to Consider Noradrenaline
Indications for Transient Use
Noradrenaline may be initiated if 1:
- Systolic BP remains <80 mmHg despite adequate fluid resuscitation
- Life-threatening hypotension threatens vital organ perfusion
- Severe hemorrhagic shock with vasodilatory component
Starting Parameters
- Initial dose: 0.1-0.5 mcg/kg/min (7-35 mcg/min in 70kg adult) 3, 4
- Target MAP: 65 mmHg as initial goal 5, 6, 7
- Administration: Via central line preferred to avoid tissue necrosis from extravasation 3, 4
Critical Caveats for the 70-Year-Old Patient
Age-Related Considerations
The 70-year-old patient requires special caution with permissive hypotension 8, 1:
- Elderly patients may have chronic hypertension requiring higher baseline pressures
- Reduced physiologic reserve tolerates hypotension poorly
- Consider targeting higher MAP (70-75 mmHg) if history of hypertension exists
Evidence Against Early/Routine Vasopressor Use
Recent high-quality trauma data shows concerning findings:
2022 multicenter study (2,164 blunt trauma patients with hemorrhagic shock): Early noradrenaline showed no mortality benefit at 24 hours or in-hospital, with ATEs ranging from -4.6 to 2.1 (not statistically significant) 9
2025 TQIP database analysis (1,049 hypotensive trauma patients): Every one-hour delay in vasopressor administration was independently associated with:
- Decreased 24-hour mortality (aOR: 0.65, P<0.001)
- Decreased in-hospital mortality (aOR: 0.65, P<0.001)
- Decreased major complications (aOR: 0.77, P=0.003)
- This suggests earlier vasopressor use may be harmful 10
2020 propensity-score analysis: High-dose noradrenaline (≥0.6 mcg/kg/min) was independently associated with:
- Higher SOFA scores at 24h (9 vs 7, P=0.003)
- Increased organ dysfunction (OR 6.69, P=0.004)
- Likely reflects inadequate volume resuscitation 11
Algorithmic Approach
Step 1: Exclude Contraindications
- Screen for TBI/spinal injury (if present, target MAP ≥80 mmHg immediately)
- Assess for chronic hypertension history
Step 2: Initial Fluid Resuscitation
- Administer crystalloids (0.9% saline or balanced crystalloid) 1
- Target systolic BP 80-90 mmHg
- Avoid excessive volumes: Coagulopathy risk increases significantly >2000 mL 8
Step 3: Vasopressor Decision Point
Only initiate noradrenaline if:
- Systolic BP <80 mmHg persists after initial fluid bolus
- Signs of critical hypoperfusion (altered mental status, oliguria, severe acidosis)
- Duration: Use only until hemorrhage control achieved, then wean rapidly
Step 4: Dosing Strategy
- Start low: 0.1 mcg/kg/min
- Titrate to MAP 65 mmHg (or 70-75 mmHg if elderly/hypertensive)
- Avoid high doses (>0.6 mcg/kg/min) as associated with worse outcomes 11
- If requiring escalating doses, suspect ongoing hemorrhage or inadequate volume resuscitation
Common Pitfalls to Avoid
Using vasopressors to compensate for inadequate volume resuscitation: Noradrenaline is relatively contraindicated in hypovolemia 3. High vasopressor requirements suggest occult blood loss.
Applying septic shock guidelines to trauma: The Surviving Sepsis Campaign guidelines 5, 6, 7 recommend noradrenaline as first-line, but these are for septic shock, not hemorrhagic shock—different pathophysiology.
Ignoring TBI: Even minor head injury changes the entire strategy—permissive hypotension becomes dangerous.
Prolonged use: Noradrenaline should be transient until hemorrhage control, not a substitute for definitive management.
Inadequate monitoring: Requires arterial line for accurate MAP monitoring 6, 7.
Summary of Evidence Quality
The strongest recent evidence specifically addressing trauma (not sepsis) suggests noradrenaline provides no mortality benefit and may be associated with harm when used early or in high doses 9, 10, 11. The 2023 European trauma guideline 1 acknowledges vasopressors may be needed for severe hypotension but emphasizes this should be transient and not routine practice.